Laquinimod-d5 Sodium Salt

• CAT Number: R056151
• CAS Number: 1354744-14-1
• Molecular Formula: C19H16ClN2NaO3
• Molecular Weight: 383.82
• Purity: ≥95%
• Synonyms: 5-Chloro-N-ethyl-1,2-dihydro-4-hydroxy-1-methyl-2-oxo-N-(phenyl-d5)-3-quinolinecarboxamide Sodium Salt; ABR 215062-d5 Sodium; N-Ethyl-N-(phenyl-d5)-1,2-dihydro-4-?hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide Sodium Salt; TV 5600-d5
• Storage: -20°C
• IUPAC Name: sodium;5-chloro-3-[ethyl-(2,3,4,5,6-pentadeuteriophenyl)carbamoyl]-1-methyl-2-oxoquinolin-4-olate
• InChI: InChI=1S/C19H17ClN2O3.Na/c1-3-22(12-8-5-4-6-9-12)19(25)16-17(23)15-13(20)10-7-11-14(15)21(2)18(16)24;/h4-11,23H,3H2,1-2H3;/q;+1/p-1/i4D,5D,6D,8D,9D
• InChIKey: JWHPPWBIIQMBQC-MPSGHZBBSA-M
• SMILES: [2H]C1=C(C(=C(C(=C1[2H])[2H])N(CC)C(=O)C2=C(C3=C(C=CC=C3Cl)N(C2=O)C)[O-])[2H])[2H].[Na+]

Laquinimod-d5 Sodium Salt（Cat No.:R056151） is a deuterated form of laquinimod, where five hydrogen atoms are replaced with deuterium, enhancing its analytical detection and stability. This modification is crucial for studying the drug’s pharmacokinetics and metabolism, particularly in neurological disorders like multiple sclerosis. Its sodium salt form improves solubility and facilitates easier handling in experimental setups. Used predominantly in mass spectrometry and NMR spectroscopy, Laquinimod-d5 Sodium Salt provides precise, reliable data, aiding researchers in developing more effective therapeutic strategies for managing and treating autoimmune and inflammatory diseases.